Search Results

There are 68282 results for: content related to: The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992–2002)

  1. Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008

    BJU International

    Volume 109, Issue 1, January 2012, Pages: 84–87, Sean P. Stroup, Kerrin Palazzi-Churas, Ryan P. Kopp and J. Kellogg Parsons

    Article first published online : 26 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10250.x

  2. Impact of medical therapy on transurethral resection of the prostate: two decades of change

    BJU International

    Volume 108, Issue 1, July 2011, Pages: 89–93, Jason Izard and J. Curtis Nickel

    Article first published online : 30 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09737.x

  3. Prostatic Surgery for Benign Prostatic Hyperplasia: Meeting the Expanding Demand

    British Journal of Urology

    Volume 72, Issue 5, November 1993, Pages: 761–765, B. M. DUNCAN and W. M. GARRAWAY

    Article first published online : 26 NOV 2008, DOI: 10.1111/j.1464-410X.1993.tb16263.x

  4. The epidemiology of benign prostatic hyperplasia: a study in Greece

    BJU International

    Volume 84, Issue 3, August 1999, Pages: 286–291, Signorello, Tzonou, Lagiou, Samoli, Zavitsanos and Trichopoulos

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1464-410x.1999.00199.x

  5. You have free access to this content
    JUA clinical guidelines for benign prostatic hyperplasia

    International Journal of Urology

    Volume 18, Issue 11, November 2011, Pages: e1–e33, Yukio Homma, Momokazu Gotoh, Osamu Yokoyama, Naoya Masumori, Akihiro Kawauchi, Tomonori Yamanishi, Osamu Ishizuka, Narihito Seki, Toshiyuki Kamoto, Atsushi Nagai and Seiichiro Ozono

    Article first published online : 3 NOV 2011, DOI: 10.1111/j.1442-2042.2011.02861.x

  6. The symptom questionnaire for benign prostatic hyperplasia: an ambiguous indicator for an ambiguous disease

    British Journal of Urology

    Volume 77, Issue 2, February 1996, Pages: 181–185, H.J. Stoevelaar, C. van de Beek, H.G.T. Nijs, A.F. Casparie, J. McDonnell and R.A. Janknegt

    Article first published online : 29 OCT 2003, DOI: 10.1046/j.1464-410X.1996.08582.x

  7. Systematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (non-inferiority)

    BJU International

    Volume 109, Issue 5, March 2012, Pages: 722–730, Katharina Biester, Guido Skipka, Rebecca Jahn, Barbara Buchberger, Volker Rohde and Stefan Lange

    Article first published online : 22 AUG 2011, DOI: 10.1111/j.1464-410X.2011.10512.x

  8. You have free access to this content
    Pharmacological Treatment for Common Prostatic Conditions in Dogs – Benign Prostatic Hyperplasia and Prostatitis: an Update

    Reproduction in Domestic Animals

    Volume 49, Issue s2, June 2014, Pages: 8–15, W Niżański, X Levy, M Ochota and J Pasikowska

    Article first published online : 20 JUN 2014, DOI: 10.1111/rda.12297

  9. Economic Burden of Treated Benign Prostatic Hyperplasia in the United Kingdom

    British Journal of Urology

    Volume 71, Issue 3, March 1993, Pages: 290–296, M. F. DRUMMOND, A. J. McGUIRE, N. A. BLACK, M. PETTICREW and C. K. McPHERSON

    Article first published online : 26 NOV 2008, DOI: 10.1111/j.1464-410X.1993.tb15945.x

  10. You have free access to this content
    Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial

    International Journal of Clinical Practice

    Volume 65, Issue 9, September 2011, Pages: 989–996, J. Carballido, R. Fourcade, A. Pagliarulo, F. Brenes, A. Boye, A. Sessa, M. Gilson and R. Castro

    Article first published online : 7 JUL 2011, DOI: 10.1111/j.1742-1241.2011.02735.x

  11. You have free access to this content
    Evidence-based meta-analysis of pharmacotherapy for benign prostatic hypertrophy

    International Journal of Urology

    Volume 9, Issue 11, November 2002, Pages: 607–612, Osamu Ishizuka, Osamu Nishizawa, Yoshihiko Hirao and Shinichi Ohshima

    Article first published online : 19 DEC 2002, DOI: 10.1046/j.1442-2042.2002.00539.x

  12. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)

    BJU International

    Volume 108, Issue 3, August 2011, Pages: 388–394, J. Curtis Nickel, Peter Gilling, Teuvo L. Tammela, Betsy Morrill, Timothy H. Wilson and Roger S. Rittmaster

    Article first published online : 1 JUN 2011, DOI: 10.1111/j.1464-410X.2011.10195.x

  13. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status

    BJU International

    Volume 85, Issue 6, April 2000, Pages: 665–671, M.H. Blanker, F.P.M.J. Groeneveld, A. Prins, R.M.D. Bernsen, A.M. Bohnen and J.L.H.R. Bosch

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-410x.2000.00570.x

  14. Trends in repeat prostatectomy after surgery for benign prostate disease: application of record linkage to healthcare outcomes

    BJU International

    Volume 84, Issue 9, December 1999, Pages: 972–975, Semmens, Wisniewski, Bass, Holman and Rouse

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-410x.1999.00359.x

  15. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake

    BJU International

    Volume 90, Issue 7, November 2002, Pages: 649–654, R. Gass

    Article first published online : 31 OCT 2002, DOI: 10.1046/j.1464-410X.2002.03001.x

  16. Prostate volume and prostate-specific antigen in the absence of prostate cancer: A review of the relationship and prediction of long-term outcomes

    The Prostate

    Volume 49, Issue 3, 1 November 2001, Pages: 208–212, Michael M. Lieber, Steven J. Jacobsen, Rosebud O. Roberts, Thomas Rhodes and Cynthia J. Girman

    Article first published online : 25 OCT 2001, DOI: 10.1002/pros.1136

  17. Are men on 5α-reductase inhibitors appropriately referred to urology? A survey of primary care physicians

    BJU International

    Volume 108, Issue 8, October 2011, Pages: 1269–1273, Faysal A. Yafi, Armen G. Aprikian, Simon Tanguay and Wassim Kassouf

    Article first published online : 24 DEC 2010, DOI: 10.1111/j.1464-410X.2010.09984.x

  18. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men

    BJU International

    Volume 101, Issue 3, February 2008, Pages: 313–318, J. Kellogg Parsons, Jaclyn Bergstrom and Elizabeth Barrett-Connor

    Article first published online : 13 NOV 2007, DOI: 10.1111/j.1464-410X.2007.07332.x

  19. The efficacy and safety of terazosin for the treatment of symptomatic BPH

    The Prostate

    Volume 18, Issue 4, 1991, Pages: 345–355, Herbert Lepor, David Henry and Atul R. Laddu

    Article first published online : 20 JUL 2006, DOI: 10.1002/pros.2990180408

  20. Urinary CD14 as a potential biomarker for benign prostatic hyperplasia – discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labeling

    PROTEOMICS - Clinical Applications

    Volume 5, Issue 3-4, April 2011, Pages: 121–132, Hong-Lin Cheng, Hung-Jen Huang, Bing-Yuan Ou, Nan-Haw Chow, Yen-Wen Chen, Tzong-Shin Tzai, Chin-Jen Wu and Shu-Hui Chen

    Article first published online : 15 FEB 2011, DOI: 10.1002/prca.201000011